The German economy is growing very dynamically in July. Plug Power grabs Tesla Gigafactory experts. Vodafone increases sales thanks to roaming revenues. Nordex is cooperating with rotor blade manufacturer TPI in Mexico. BMW stops production in Leipzig due to a lack of chips. VW Group is likely to continue to be burdened by the lack of chips – production throttling threatens. Transfer von Malen to BVB apparently before completion. The Frankfurt trade is characterized by profits on Friday.
The DAX marked its opening price at 0.57 percent and 15,603.69 points. Even afterward it remains in the profit zone. At the start of the stock exchange, the TecDAX presented itself with a premium of 0.38 percent to 3,662.48 points, which it continues to maintain.
An eventful week on the stock market is coming to an end. After the massive slide in the German benchmark index on Monday to just over 15,000 points, it was able to recover and consolidate in the following days, so that it is virtually unchanged weekly. At the end of the week, investors are still focusing on economic data, which are expected in the course of the day. In addition, investors are also betting on a persistent glut of money in the eurozone, as the ECB has reaffirmed its commitment to an ultra-loose monetary policy. On Thursday, the European Central Bank reaffirmed its expansionary course with interest rates at a record low and billions in bond purchases. The particularly flexible emergency purchase program for government bonds and corporate securities launched at the beginning of the corona pandemic will be continued until at least the end of March 2022. The concerns of investors with a view to the rapid spread of the delta variant of the coronavirus moved a little further into the background.
The shop pharmacy should move into a focus on the German stock market. The forecast for sales growth in 2021 has been reduced to ten to 15 percent – a lack of staff is putting the board of directors through the annual planning. On the economic side, the mood barometers of German and European purchasing managers are on the schedule. Experts do not expect any major changes in either case.
Biontech share at record high – high effectiveness of the vaccine against Delta variant:
Already on Thursday in late trading, the papers of the German vaccine manufacturer BioNTech rose by almost 10 percent to a record high of 241 euros. According to a study, the biotech company’s coronavirus vaccine is almost as effective against the particularly infectious Delta variant as it is against the original type of pathogen.
Dax Long (Buy)
ENTER AT: 15659.396